Document Classification

Section Type: RESULTS

Text: Significant improvement was observed with paliperidone palmitate 156-mg or 234-mg versus placebo in least-squares mean (SE) score change at end point in PANSS total (156 mg, -15. 8 [3. 0], p = 0. 0001 ; 234 mg, -17. 6 [3. 2], p = 0. 0001), CGI-S (156 mg, -0. 9 [0. 2], p = 0. 0068 ; 234 mg, -1. 1 [0. 2], p = 0. 0003), and PSP (156 mg, 10. 7 [2. 3], p = 0. 0061 ; 234 mg, 12. 9 [2. 4], p = 0. 0009).